ADA University of Tartu Library
metadata only
Investigating chaga supplementation in type 2 diabetes: A novel prospective trial of metabolic, cognitive, and microbiome effects
Type 2 diabetes mellitus (T2DM) manifests as chronic hyperglycaemia, insulin-resistance-driven neurocognitive decline, and gut microbiota perturbation. Preclinical studies show that polysaccharides, triterpenoids and polyphenols from Inonotus obliquus (Chaga) activate PI3K/Akt-GLUT4 translocation, p
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Diabetes-Associated Cognitive Dysfunction: Pathophysiology, Molecular Mechanisms, and Emerging Therapeutic Strategies.#1346456
- Polydatin Reverses Diabetes-Induced Apoptosis of Pancreatic β-Cells by Inhibiting the TNF/TNF-R1/Caspase-3 Signaling Axis.#785877
- Novel idebenone analogs block Shc’s access to insulin receptor to improve insulin sensitivity#1263492
- A Clinical Study to Evaluate the Effects of Akkermansia Muciniphila and Berberine on Prediabetes Among Obese Subjects.#901111
- Effect of Acarbose and Mixture of Pioglitazone and Metformin in Patients With Type 2 Diabetes#146431
Record · ID 1194053
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive